Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection (Q45522377)

14 December 2017

Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection (English)

1 reference

14 December 2017

0 references

6

Roger J Pomerantz

1 reference

14 December 2017

Elena I Marusich

1

1 reference

14 December 2017

Zahida Parveen

2

1 reference

14 December 2017

David Strayer

3

1 reference

14 December 2017

Muhammad Mukhtar

4

1 reference

14 December 2017

Ralph C Dornburg

5

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

14 December 2017

1 reference

14 December 2017

332

1 reference

14 December 2017

1

1 reference

14 December 2017

258-271

1 reference

Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Gene therapy. Intracellular immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Retroviral vector system for the study of cDNA gene formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Transcriptional control: an essential component of cancer gene therapy strategies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

De novo methylation and expression of retroviral genomes during mouse embryogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Antiviral potency of drug-gene therapy combinations against human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

New Procedure for DNA Transfection with Polycation and Dimethyl Sulfoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Neuropathology of fetal nigra transplants for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Cell-type-specific gene delivery into neuronal cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Twenty years of therapy for HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

Progress and problems with the use of viral vectors for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

The U3 region is not necessary for 3' end formation of spleen necrosis virus RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.11.012

1 reference

14 December 2017

1 reference